Optibrium Launches Cerella, an artificial intelligence software platform for drug discovery that delivers active learning using advanced deep learning methods
Novel features include a unique pKa model, combining quantum mechanics and machine learning methods, and extended capabilities in structure-based design
Partnership combines Intellegens’ proprietary AI technology with Optibrium’s expertise in predictive modeling and compound design
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.